Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model
Top Cited Papers
- 14 November 2001
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 315 (3) , 149-153
- https://doi.org/10.1016/s0304-3940(01)02326-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A randomized, placebo-controlled trial of coenzyme Q 10 and remacemide in Huntington’s diseaseNeurology, 2001
- Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in miceNature Medicine, 2000
- Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's DiseaseJournal of Neuroscience, 2000
- Mitochondrial dysfunction in neurodegenerative diseasesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1998
- Coenzyme Q 10 administration increases brain mitochondrial concentrations and exerts neuroprotective effectsProceedings of the National Academy of Sciences, 1998
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD MutationCell, 1997
- Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal gangliaAnnals of Neurology, 1997
- Mitochondrial defect in Huntington's disease caudate nucleusAnnals of Neurology, 1996
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993